Literature DB >> 28712106

Sensitivity and specificity of urinalysis samples in critically ill patients.

Sean P Lee, Terrie Vasilopoulos, Thomas James Gallagher1.   

Abstract

BACKGROUND: Pre-emptive screening of urine for patients admitted to an intensive care unit can result in the misinterpretation of data and over- or under-treatment of urinary tract infection.
METHODS: Data were studied from 169 consecutive patients admitted to the neurologic or burn intensive care unit at Shands Hospital at the University of Florida. All patients had a urinary catheter in place at the time of admission. Urinalysis and urine culture were sent for analysis. Data included leukocyte esterase, urine nitrate, urine protein, pyuria or urine white blood cell count, and culture.
RESULTS: Leukocyte esterase and pyuria were the most sensitive indicators of a positive urine culture at 87.5% (95% CI: 71.3-100%) and 73.3% (95% CI: 51.0-95.7%), respectively; urine nitrate was specific at 100%. More than half of the patients (56.3%) with positive cultures did not initially receive antibiotics.
CONCLUSION: The combination of leukocyte esterase and urine nitrate provides the best indicator for the initiation of antibiotic coverage for urinary tract infection prior to culture availability.

Entities:  

Keywords:  leukocyte esterase; urinary tract infection; urine nitrate; urine protein; urine white blood cell count

Mesh:

Substances:

Year:  2017        PMID: 28712106     DOI: 10.5603/AIT.a2017.0036

Source DB:  PubMed          Journal:  Anaesthesiol Intensive Ther        ISSN: 1642-5758


  2 in total

Review 1.  Diagnosing Catheter-associated Urinary Tract Infection in Critically Ill Patients: Do the Guidelines Help?

Authors:  Sai Saran; Namrata S Rao; Afzal Azim
Journal:  Indian J Crit Care Med       Date:  2018-05

2.  Catheter-associated urinary tract infection reduction in critical care units: a bundled care model.

Authors:  Stephanie Grana Van Decker; Nicholas Bosch; Jaime Murphy
Journal:  BMJ Open Qual       Date:  2021-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.